| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.052 | 0.4 |